Here are the biggest analyst calls of the day: Amazon, Chevron, Activision Blizzard & more

Here’s the opinion of Wall Street analysts for the beginning of 2 Q:


Increases Amazon’s Amazon Target (AMZN.US) from $ 1975 to $ 2085

Morgan Stanley:

Determines Chevron Inc (CVX.US) shares of “overweight” as analysts see a positive cash flow to the company as well as an increase in output of 3-4% a year for the next five years.

JP Morgan:

Lower Hain (HAIN.US) from “overweight” to “neutral,” as the rationale for analysts pointed to 30% growth since early 2019. which is a pretty good performance of Hain.


Upgrade of UPS (UPS.US) from “Hold” to “Buy” after the company showed a strong presence in Europe with the B2B service.


Increased expectations for pharmaceutical giant Astrazeneca (AZN.US) from “market perform” to “outperform”, analysts expect the company to make a deal for a drug that helps to treat breast cancer.


Add Activision Blizzard (ATVI.US) as “best idea” due to the high expectations for the company’s development in 2019.

Keefe, Bruyette, & Woods:

Wells Fargo dropped from “outperform” to “market perform” due to the lack of a new CEO of the company and negative expectations for 2019.


Upgraded FedEx from “hold” to “buy” for improvement in services in several countries and successful acquisition of TNT

 Trader Velizar Mitov

Read more:
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance